Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Avalon Globocare (AVCO)

Avalon Globocare (AVCO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,707
  • Shares Outstanding, K 88,955
  • Annual Sales, $ 1,390 K
  • Annual Income, $ -9,090 K
  • 60-Month Beta 0.83
  • Price/Sales 29.55
  • Price/Cash Flow N/A
  • Price/Book 31.96
Trade AVCO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings -0.02 on 05/11/22
  • Next Earnings Date 05/13/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4006 +25.34%
on 05/18/22
0.6679 -24.82%
on 04/25/22
-0.1579 (-23.92%)
since 04/22/22
3-Month
0.4006 +25.34%
on 05/18/22
0.8498 -40.92%
on 03/21/22
-0.2349 (-31.87%)
since 02/24/22
52-Week
0.4006 +25.34%
on 05/18/22
1.5700 -68.02%
on 06/14/21
-0.6179 (-55.17%)
since 05/24/21

Most Recent Stories

More News
Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies

Leveraging Avalon’s existing Flash-CARTM technology platform to develop next-generation mRNA-based CAR-NK cellular therapeuticsClinical development of...

AVCO : 0.5021 (+4.58%)
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs

Company continues to expand and accelerate its R&D strategies for high-impact translational and clinical programs in the US and Europe Intended...

AVCO : 0.5021 (+4.58%)
Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market

Avalon’s Chairman converts $3.0 million of debt into common stock at $1.25 per share showing continued confidence and support of the business...

AVCO : 0.5021 (+4.58%)
Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development

Avalon and research partner, Massachusetts Institute of Technology (MIT), combine their protein design “QTY Code” technology with Google’s DeepMind...

AVCO : 0.5021 (+4.58%)
Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy

Co-developed novel technology platform combining S-layer proteins and emulsomes for diverse applications in bio-delivery of drugs and genes with the...

AVCO : 0.5021 (+4.58%)
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases

Avalon and research partner, University of Natural Resources and Life Sciences (BOKU), in Vienna, Austria, co-develop a novel technology to efficiently...

AVCO : 0.5021 (+4.58%)
Avalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30th

FREEHOLD, N.J., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today...

AVCO : 0.5021 (+4.58%)
Sysorex Elects Nasdaq-Listed Company CEO William Stilley to Board of Directors

HERNDON, Va., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sysorex (OTCQB: SYSX) (“Sysorex” or the “Company”), the preeminent, U.S.-based, publicly traded Ethereum mining and technologies company, today...

SYSX : 0.0711 (+10.23%)
ADIL : 1.3100 (-4.38%)
AVCO : 0.5021 (+4.58%)
AVALON GLOBOCARE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Avalon GloboCare Corp. - AVCO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Hebei Senlang Biotechnology Co. Ltd. to Avalon...

AVCO : 0.5021 (+4.58%)
UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare

PITTSBURGH, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A new collaboration among UPMC Hillman Cancer Center , the University of Pittsburgh and New Jersey-based biotechnology company Avalon GloboCare Corp....

AVCO : 0.5021 (+4.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Avalon GloboCare Corp. outsourced healthcare services. It serves healthcare institutions, individual patients, academia and corporations sector. The company provides healthcare management which comprises cell-based technologies and therapeutics, genomic diagnostics and precision medicine, international...

See More

Key Turning Points

3rd Resistance Point 0.5747
2nd Resistance Point 0.5474
1st Resistance Point 0.5247
Last Price 0.5021
1st Support Level 0.4747
2nd Support Level 0.4474
3rd Support Level 0.4247

See More

52-Week High 1.5700
Fibonacci 61.8% 1.1233
Fibonacci 50% 0.9853
Fibonacci 38.2% 0.8473
Last Price 0.5021
52-Week Low 0.4006

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar